Manufacturers Life Insurance Company, The Intellia Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

  • $108 Billion
  • Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 53,545 shares of NTLA stock, worth $652,178. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53,545
Previous 54,192 1.19%
Holding current value
$652,178
Previous $1.21 Million 9.24%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$19.72 - $27.36 $12,758 - $17,701
-647 Reduced 1.19%
53,545 $1.1 Million
Q2 2024

Aug 14, 2024
SELL
$20.02 - $27.22 $239,719 - $325,932
-11,974 Reduced 18.1%
54,192 $1.21 Million
Q1 2024

May 14, 2024
BUY
$23.82 - $32.8 $69,911 - $96,267
2,935 Added 4.64%
66,166 $1.82 Million
Q4 2023

Feb 13, 2024
SELL
$23.16 - $32.34 $121,914 - $170,237
-5,264 Reduced 7.69%
63,231 $1.93 Million
Q3 2023

Nov 15, 2023
BUY
$31.62 - $45.78 $339,946 - $492,180
10,751 Added 18.62%
68,495 $2.17 Million
Q2 2023

Aug 11, 2023
SELL
$34.58 - $46.03 $211,041 - $280,921
-6,103 Reduced 9.56%
57,744 $2.35 Million
Q1 2023

May 15, 2023
BUY
$33.3 - $44.82 $10,755 - $14,476
323 Added 0.51%
64,170 $2.39 Million
Q4 2022

Aug 11, 2023
BUY
$33.21 - $62.69 $322,004 - $607,842
9,696 Added 17.91%
63,847 $2.23 Million
Q4 2022

Feb 13, 2023
BUY
$33.21 - $62.69 $322,004 - $607,842
9,696 Added 17.91%
63,847 $2.23 Million
Q3 2022

Aug 11, 2023
SELL
$53.92 - $71.7 $29,224 - $38,861
-542 Reduced 0.99%
54,151 $3.03 Million
Q3 2022

Nov 03, 2022
SELL
$53.92 - $71.7 $29,224 - $38,861
-542 Reduced 0.99%
54,151 $3.01 Million
Q2 2022

Aug 11, 2023
BUY
$38.49 - $76.21 $188,331 - $372,895
4,893 Added 9.83%
54,693 $2.83 Million
Q2 2022

Aug 15, 2022
BUY
$38.49 - $76.21 $188,331 - $372,895
4,893 Added 9.83%
54,693 $2.85 Million
Q1 2022

Aug 11, 2023
SELL
$58.27 - $118.99 $837,339 - $1.71 Million
-14,370 Reduced 22.39%
49,800 $3.62 Million
Q1 2022

May 20, 2022
BUY
$58.27 - $118.99 $861,288 - $1.76 Million
14,781 Added 42.21%
49,800 $3.61 Million
Q4 2021

Feb 16, 2022
BUY
$100.76 - $138.36 $21,663 - $29,747
215 Added 0.62%
35,019 $4.18 Million
Q3 2021

Nov 12, 2021
SELL
$132.37 - $176.78 $99,806 - $133,292
-754 Reduced 2.12%
34,804 $4.67 Million
Q2 2021

Aug 12, 2021
BUY
$60.88 - $161.91 $295,755 - $786,558
4,858 Added 15.82%
35,558 $5.76 Million
Q1 2021

May 03, 2021
BUY
$46.59 - $83.68 $33,451 - $60,082
718 Added 2.39%
30,700 $2.46 Million
Q4 2020

Feb 12, 2021
BUY
$18.83 - $63.53 $31,370 - $105,840
1,666 Added 5.88%
29,982 $1.63 Million
Q3 2020

Nov 09, 2020
BUY
$17.47 - $24.93 $34,520 - $49,261
1,976 Added 7.5%
28,316 $563,000
Q2 2020

Aug 10, 2020
BUY
$11.14 - $22.87 $10,872 - $22,321
976 Added 3.85%
26,340 $538,000
Q1 2020

May 15, 2020
BUY
$9.44 - $15.58 $13,461 - $22,217
1,426 Added 5.96%
25,364 $310,000
Q4 2019

Feb 14, 2020
SELL
$10.43 - $17.67 $2,200 - $3,728
-211 Reduced 0.87%
23,938 $351,000
Q3 2019

Nov 12, 2019
BUY
$13.07 - $18.51 $6,142 - $8,699
470 Added 1.98%
24,149 $322,000
Q2 2019

Aug 14, 2019
BUY
$13.88 - $18.41 $13,449 - $17,839
969 Added 4.27%
23,679 $388,000
Q1 2019

May 13, 2019
BUY
$12.79 - $17.62 $22,216 - $30,605
1,737 Added 8.28%
22,710 $387,000
Q4 2018

Feb 14, 2019
SELL
$11.39 - $27.13 $14,601 - $34,780
-1,282 Reduced 5.76%
20,973 $287,000
Q3 2018

Nov 14, 2018
SELL
$25.78 - $32.6 $74,813 - $94,605
-2,902 Reduced 11.54%
22,255 $637,000
Q2 2018

Aug 14, 2018
BUY
$20.02 - $30.79 $235,315 - $361,905
11,754 Added 87.7%
25,157 $689,000
Q1 2018

May 15, 2018
SELL
$19.43 - $34.95 $4,818 - $8,667
-248 Reduced 1.82%
13,403 $283,000
Q4 2017

Feb 08, 2018
BUY
$17.39 - $31.12 $24,154 - $43,225
1,389 Added 11.33%
13,651 $262,000
Q3 2017

Nov 14, 2017
BUY
$15.16 - $25.75 $185,891 - $315,746
12,262
12,262 $304,000

Others Institutions Holding NTLA

# of Institutions
314
Shares Held
91.5M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $926M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email